Back to
VANGUARD GROUP INC
TNXP4 quarters
Position history for
VANGUARD GROUP INC's holdings in TONIX PHARMACEUTICALS HOLDIN
As of its last 13F, for Q4 2025, Vanguard Group held 673,605 shares of TNXP (Tonix Pharmaceuticals Holdin), worth $10.5M. It increased the position by 116,648 shares (+20.9%) from Q3 2025. Vanguard Group held TNXP from Q1 2025 to Q4 2025, across 4 quarterly 13F filings.
Current Value
$10.5M
Current Shares
673,605
Total Value Change
+$8.9M
Total Shares Change
+582,109
Quarter-by-Quarter History
Other major holders of TNXP: BlackRock, Inc., Point72 Asset Management, L.P.